Evaluation of Heterosubtypic Immune Responses in Older People Before and After Seasonal and Pandemic Influenza Vaccination
Phase of Trial: Phase I
Latest Information Update: 28 Jul 2015
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary) ; Influenza virus vaccine; MF 59
- Indications Influenza A virus H5N1 subtype; Influenza virus infections
- Focus Pharmacodynamics
- 02 Jun 2014 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 07 Aug 2012 Planned End Date changed from 1 Aug 2010 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 28 Oct 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.